Regulation of Synaptic Plasticity By SWI5-SFR1 Complex (P25025)

Target Name: SWI5-SFR1 complex

NCBI ID: P25025

SWI5-SFR1 complex

Other Name(s): Swi5-Mei5 complex

Regulation of Synaptic Plasticity By SWI5-SFR1 Complex

The SWI5-SFR1 complex, also known as the Swi5-Mei5 complex, is a protein complex that is found in the endoplasmic reticulum (ER) and is involved in the regulation of synaptic plasticity, a critical process that involves the strengthening and modification of neural connections. The SWI5-SFR1 complex is composed of two subunits, SWI5 and SFR1, which are encoded by the genes SNORD2 and NSR1, respectively.

The SWI5 gene encodes a protein that is highly conserved across various species, including humans, and is known to be involved in the regulation of synaptic plasticity. Specifically, SWI5 is known to be involved in the regulation of the strengthening and stability of synaptic connections, as well as the modulation of neurotransmitter release.

The SFR1 gene encodes a protein that is also known as Calbindin, a well-known protein that is involved in the regulation of synaptic plasticity. Calbindin is known to play a critical role in the formation and maintenance of synaptic connections, as well as the regulation of neurotransmitter release.

The SWI5-SFR1 complex is thought to function as a protein complex that is involved in the regulation of synaptic plasticity. The complex is composed of two subunits, SWI5 and SFR1, which are encoded by the genes SNORD2 and NSR1, respectively. The SWI5 gene encodes a protein that is highly conserved across various species and is known to be involved in the regulation of synaptic plasticity. The SFR1 gene encodes a protein that is also known as Calbindin, a well-known protein that is involved in the regulation of synaptic plasticity.

The SWI5-SFR1 complex is thought to function as a protein complex that is involved in the regulation of synaptic plasticity. The complex is composed of two subunits, SWI5 and SFR1, which are encoded by the genes SNORD2 and NSR1, respectively. The Swi5 gene encodes a protein that is highly conserved across various species and is known to be involved in the regulation of synaptic plasticity. The Sfr1 gene encodes a protein that is also known as Calbindin, a well-known protein that is involved in the regulation of synaptic plasticity.

The function of the SWI5-SFR1 complex is not well understood, but it is thought to play a critical role in the regulation of synaptic plasticity. The complex is known to be involved in the regulation of the strengthening and stability of synaptic connections, as well as the modulation of neurotransmitter release.

One of the key functions of the SWI5-SFR1 complex is the regulation of synaptic plasticity. Synaptic plasticity is the ability of the nervous system to change and adapt over time, and is critical for the development and maintenance of complex behaviors. The SWI5-SFR1 complex is thought to be involved in the regulation of synaptic plasticity by controlling the strengthening and stability of synaptic connections and the modulation of neurotransmitter release.

Another function of the SWI5-SFR1 complex is the regulation of neurotransmitter release. Neurotransmitters are the chemical messengers that are used by the nervous system to communicate with other cells and are involved in the regulation of a wide range of physiological processes. The SWI5-SFR1 complex is thought to be involved in the regulation of neurotransmitter release by controlling the strengthening and stability of synaptic connections.

The SWI5-SFR1 complex is also thought to be involved in the regulation of the formation and maintenance of synaptic connections. Synaptic connections are the connections between neurons

Protein Name: SWI5-SFR1 Complex

The "SWI5-SFR1 complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SWI5-SFR1 complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets